An interventional study of 3D group and normal group in Infertility, Female, sponsored by Shanghai First Maternity and Infant Hospital. Status unknown. Open to female participants aged 25 Years to 35 Years. Per ClinicalTrials.gov, last updated 2016-10-28.
Sponsored by Shanghai First Maternity and Infant Hospital · Not applicable, Interventional, and Treatment
This study intends to carry out a prospective, randomized controlled trial to compare the trans-umbilical laparoendoscopic single-site surgery by 3D laparoscopy with normal laparoendoscopic surgery in the treatment of infertility patient, so as to further clarify the safety and curative effect of TU-LESS by 3D laparoscopy and provide evidence-based basis for its application in infertility population.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's planned enrollment of 500 is above the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →Shanghai First Maternity and Infant Hospital is the lead sponsor of 45 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
infertility patient get TU-LESS by 3D Laparoscopy
Procedure: 3D group
infertility patient get normal laparoscopic surgery
Procedure: normal group
infertility patient get TU-LESS by 3D Laparoscopy
infertility patient get normal laparoscopic surgery
pain score
Visual Analogue Score for the pain feeling of the patient
Time frame: in 24 hours after surgery
pregnancy rate
Time frame: 6 months after surgery
Operation time
Time frame: intraoperative
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai First Maternity and Infant Hospital